|
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical research trials and A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer. A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer clinical trial. Participants frequently obtain the most expert healthcare available for their A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer  A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
For Condition: Non-small cell lung cancer
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with non-small cell lung cancer. Patients will receive ABT-751 by mouth daily for 21 days. Patients will be off drug for 7 days before starting the next cycle of drug.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Stage IIIB or IV non-small cell lung cancer. - Recurrent tumor following treatment with paclitaxel or docetaxel. - Not pregnant or breast feeding. - Able to tolerate normal activites of daily living. - No anti-tumor therapy within 4 weeks of the start of ABT-751 administration. - No CNS metastasis. - Adequate bone marrow, kidney and liver function.
Total Enrollment:
Location and Contact Information:
Cancer Care Northwest *Recruiting*
Spokane, Washington,
United States
Recruiting Rosalee Miller 509-464-5100
West Cancer Clinic *Recruiting*
Memphis, Tennessee, 38120
United States
Recruiting Marnie Brotherton 901-683-0055
Florida Cancer Institute *Recruiting*
New Port Richey, Florida,
United States
Recruiting Greta Nobles 727-842-8411
Cancer Centers of the Carolinas *Recruiting*
Greenville, South Carolina,
United States
Recruiting Janis Barrieau 864-987-7000
University of Maryland Greenbaum Cancer Center *Recruiting*
Baltimore, Maryland, 21201-1595
United States
Recruiting Ruth Smith 410-328-9166
University of Chicago Medical Center *Recruiting*
Chicago, Illinois, 60637-1460
United States
Recruiting Livia Szeto 773-834-0783
University of Wisconsin Comprehensive Cancer Center *Recruiting*
Madison, Wisconsin, 53792-5666
United States
Recruiting Lana Hammes 608-262-8126
Albany Regional Cancer Center *Recruiting*
Albany, New York,
United States
Recruiting James Arsneau 518-489-2607
Texas Oncology *Recruiting*
Ft. Worth, Texas,
United States
Recruiting Robert Ruxer 817-338-4333
Oncology & Hematology Associates of Kansas City, PA *Recruiting*
Kansas City, Missouri, 64111
United States
Recruiting Vickie Thomas 913-514-4641
Raleigh Hematology Oncology *Recruiting*
Cary, North Carolina,
United States
Recruiting Diane Bracco 919-852-1994
Oncology Hematology Group of South Florida *Recruiting*
Miami, Florida,
United States
Recruiting Kathy Maxwell 901-683-0055
Cancer Care Associates *Recruiting*
Oklahoma City, Oklahoma,
United States
Recruiting Nancy Cleaner 405-751-4343
Northwest Cancer Specialists *Recruiting*
Vancouver, Washington,
United States
Recruiting Judith Welch 360-944-9889
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63110-1093
United States
Recruiting Linda Dunn 314-747-1849
Texas Oncology *Recruiting*
Dallas, Texas,
United States
Recruiting Kristi McIntyre 214-739-4175
Texas Oncology *Recruiting*
Dallas, Texas,
United States
Recruiting Joanne Blum 214-370-1000
Dayton Oncology and Hematology *Recruiting*
Kettering, Ohio,
United States
Recruiting Michele Owens 937-293-1622
Additional Information:
Study ID Numbers: M02-448;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073151
Other Non-Small Cell Lung Cancer Studies:
1. Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients with Advanced Non-Small Cell Lung Cancer
2. Docetaxel and Gemcitabine with Filgrastim-SD/01 Support in Patients with Advanced Non-Small Cell Lung Carcinoma
3. Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
4. Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
5. Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients
Related Studies:
Other Non-small cell lung cancer Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
|
|
|
|
|
|
|
|
